These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36452124)

  • 1. Analgesic potential of macrodoses and microdoses of classical psychedelics in chronic pain sufferers: a population survey.
    Bonnelle V; Smith WJ; Mason NL; Cavarra M; Kryskow P; Kuypers KP; Ramaekers JG; Feilding A
    Br J Pain; 2022 Dec; 16(6):619-631. PubMed ID: 36452124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential analgesic effects of psychedelics on select chronic pain conditions: A survey study.
    Cavarra M; Mason NL; Kuypers KPC; Bonnelle V; Smith WJ; Feilding A; Kryskow P; Ramaekers JG
    Eur J Pain; 2024 Jan; 28(1):153-165. PubMed ID: 37599279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microdosing psychedelics: Motivations, subjective effects and harm reduction.
    Lea T; Amada N; Jungaberle H; Schecke H; Klein M
    Int J Drug Policy; 2020 Jan; 75():102600. PubMed ID: 31778967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers.
    Hutten NRPW; Mason NL; Dolder PC; Kuypers KPC
    Front Psychiatry; 2019; 10():672. PubMed ID: 31572246
    [No Abstract]   [Full Text] [Related]  

  • 5. Psychedelic Drug Microdosing Practices: A Qualitative Online Exploration.
    Miller E; Bojovic V; Maddren O; Rao P; Adesina D; Petrenko A; Ponton R
    J Psychoactive Drugs; 2024 Jan; ():1-10. PubMed ID: 38247351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latin American adults who regularly use macrodoses of psychedelics: a cross-sectional study.
    Véliz-García O; Domic-Siede M
    Sci Rep; 2024 Oct; 14(1):23921. PubMed ID: 39397094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are psychedelics the answer to chronic pain: A review of current literature.
    Kooijman NI; Willegers T; Reuser A; Mulleners WM; Kramers C; Vissers KCP; van der Wal SEI
    Pain Pract; 2023 Apr; 23(4):447-458. PubMed ID: 36597700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experiences of microdosing psychedelics in an attempt to support wellbeing and mental health.
    Ryan RS; Copello A; Fox AP
    BMC Psychiatry; 2023 Mar; 23(1):160. PubMed ID: 36918852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microdosing psychedelics: personality, mental health, and creativity differences in microdosers.
    Anderson T; Petranker R; Rosenbaum D; Weissman CR; Dinh-Williams LA; Hui K; Hapke E; Farb NAS
    Psychopharmacology (Berl); 2019 Feb; 236(2):731-740. PubMed ID: 30604183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the effect of microdosing psychedelics on creativity in an open-label natural setting.
    Prochazkova L; Lippelt DP; Colzato LS; Kuchar M; Sjoerds Z; Hommel B
    Psychopharmacology (Berl); 2018 Dec; 235(12):3401-3413. PubMed ID: 30357434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. If the Doors of Perception Were Cleansed, Would Chronic Pain be Relieved? Evaluating the Benefits and Risks of Psychedelics.
    Dworkin RH; Anderson BT; Andrews N; Edwards RR; Grob CS; Ross S; Satterthwaite TD; Strain EC
    J Pain; 2022 Oct; 23(10):1666-1679. PubMed ID: 35643270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic pain and psychedelics: a review and proposed mechanism of action.
    Castellanos JP; Woolley C; Bruno KA; Zeidan F; Halberstadt A; Furnish T
    Reg Anesth Pain Med; 2020 Jul; 45(7):486-494. PubMed ID: 32371500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scoping Review: The Role of Psychedelics in the Management of Chronic Pain.
    Robinson CL; Fonseca ACG; Diejomaoh EM; D'Souza RS; Schatman ME; Orhurhu V; Emerick T
    J Pain Res; 2024; 17():965-973. PubMed ID: 38496341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microdosing psilocybin for chronic pain: a case series.
    Lyes M; Yang KH; Castellanos J; Furnish T
    Pain; 2023 Apr; 164(4):698-702. PubMed ID: 36066961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrodosing to microdosing with psychedelics: Clinical, social, and cultural perspectives.
    Kaypak AC; Raz A
    Transcult Psychiatry; 2022 Oct; 59(5):665-674. PubMed ID: 36031848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-Medication for Chronic Pain Using Classic Psychedelics: A Qualitative Investigation to Inform Future Research.
    Bornemann J; Close JB; Spriggs MJ; Carhart-Harris R; Roseman L
    Front Psychiatry; 2021; 12():735427. PubMed ID: 34867525
    [No Abstract]   [Full Text] [Related]  

  • 17. Beating pain with psychedelics: Matter over mind?
    Elman I; Pustilnik A; Borsook D
    Neurosci Biobehav Rev; 2022 Mar; 134():104482. PubMed ID: 34922987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine Associations Underlying the Persistent Therapeutic Effects of Classic Serotonergic Psychedelics.
    Schindler EAD; Wallace RM; Sloshower JA; D'Souza DC
    Front Pharmacol; 2018; 9():177. PubMed ID: 29545753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perceived outcomes of psychedelic microdosing as self-managed therapies for mental and substance use disorders.
    Lea T; Amada N; Jungaberle H; Schecke H; Scherbaum N; Klein M
    Psychopharmacology (Berl); 2020 May; 237(5):1521-1532. PubMed ID: 32043165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychedelics as preventive treatment in headache and chronic pain disorders.
    Schindler EAD
    Neuropharmacology; 2022 Sep; 215():109166. PubMed ID: 35718005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.